Responding to a Public Health Objection to Vaccinating the Great Apes
Tóm tắt
Capps and Lederman, in a paper published in this journal in 2015, argued that, at the time, the dismal circumstances of the Ebola outbreak in West Africa was an opportunity to revisit public health responses to emergent infectious diseases. Using a One Health lens, they argued for an ecological perspective—one that looked to respond to zoonoses as an environmental as well as public health concern. Using Ebola virus disease as an example, they suggested shared immunity as a strategy to vaccinate both humans and great apes. Since then, vaccination as a conservation strategy in this case has been debated and at least one great ape vaccination trial has been proposed: some, however, are less convinced of the ethical arguments to pursue vaccinating wild animals. Using this opportunity, we review Capps and Lederman’s arguments and directly respond to the plausible objections to them.
Tài liệu tham khảo
Adams, H., et al. (2001). Self-reported medical history survey of humans as a measure of health risk to the chimpanzees (Pan troglodytes schweinfurthii) of Kibale National Park, Uganda. Oryx, 35, 308–312.
Adebamowo, C., et al. (2014). Randomised controlled trials for ebola: Practical and ethical issues. Lancet, 384, 1423–1424.
Aisling, A., et al. (2016). Self-disseminating vaccines for emerging infectious diseases. Expert Review of Vaccines, 15, 31–39.
Ani, S. (2009). Animals as vulnerable subjects: beyond interest-convergence, hierarchy, and property. Animal Law Review, 16, 65–122.
Bausch, D., & Schwarz, L. (2014). Outbreak of ebola virus disease in Guinea: Where ecology meets economy. PLoS Neglected Tropical Disease, 8, e3056.
Breed, A., et al. (2010). Bats without borders: Long-distance movements and implications for disease risk management. EcoHealth, 7, 204–212.
Brownsword, R. (2011). Responsible regulation: Prudence, precaution and Stewardship. Northern Ireland Legal Quarterly, 62, 573–597.
Capps, B., & Lederman, Z. (2015). One Health, vaccines and ebola: The opportunities for shared benefits. Journal of Agriculture and Environmental Ethics, 28, 1011–1032.
Capps, B., et al. (2015). Introducing one health to the ethical debate about zoonotic diseases in South East Asia. Bioethics, 29, 588–596.
Cavalieri, P., & Singer, P. (Eds.) (1993). The Great Ape Project. New York: St. Martin's Griffin.
Dick, G., Kitchen, S., & Haddow, A. (1952). Zika virus (I) isolations and serological specificity. Transactions of the Royal Society of Tropical Medicine and Hygiene, 46, 509–520.
Dowdle, W., & Birmingham, M. (1997). The biologic principles of poliovirus eradication. Journal of Infectious Diseases, 175(Suppl 1), S286–S292.
Folayan, M. & Haire, B. (2015). Ethical considerations in the conduct of research on therapies for the prevention and treatment of ebola virus disease in developing countries. Pan African Medical Journal, 22(Suppl 1), 8
Graham, J. (2016). Ambiguous capture: Collaborative capitalism and the meningitis vaccine project. Medical anthropology: Cross-cultural studies in health and illness. http://dx.doi.org/10.1080/01459740.2016.1167055
Hastings, B., Kenny, D., Lowenstine, L., & Foster J. (1991). Mountain gorillas and measles: Ontogeny of a wildlife vaccination program. Proceedings of the American Association of Zoo Veterinarians Annual Conference (pp. 198–205).
Holm, S., & Harris, J. (1999). Precautionary principle stifles discovery. Nature, 400, 398.
Kaebnick, G. (2014). Humans in nature. The world as we find it and the world as we create it. Oxford: Oxford University Press.
Kelly, L., et al. (2014). Vaccinating captive chimpanzees to save wild chimpanzees. PNAS, 111, 8873–8876.
Leendertza, F., et al. (2006). Pathogens as drivers of population declines: The importance of systematic monitoring in great apes and other threatened mammals. Infectious Disease and Mammalian Conservation, 131, 325–337.
Lewis, D. (2016). Can great apes be vaccinated against ebola and other diseases? Smithsonian.com, April 12. http://www.smithsonianmag.com/smart-news/scientists-are-trying-vaccinate-great-apes-against-ebola-and-other-diseases-180958725/?no-ist.
Makanga, B., et al. (2016). Ape malaria transmission and potential for ape-to-human transfers in Africa. PNAS. doi:10.1073/pnas.1603008113.
Marzi, A., et al. (2016). Cytomegalovirus-based vaccine expressing ebola virus glycoprotein protects nonhuman primates from ebola virus infection. Scientific Reports. doi:10.1038/srep21674.
Mohammadi, D. (2015). Ebola vaccine trials back on track. World Report, 385, 214–215.
Ng, S., Basta, N. & Cowling, B. (2014). Association between temperature, humidity and ebolavirus disease outbreaks in Africa, 1976 to 2014. Eurosurveillance. doi:10.2807/1560-7917.ES2014.19.35.20892.
Osofsky, et al. (2016). Plan it for the apes: Sound Science must inform any plans to vaccinate gorillas or chimps against Ebola. LinkedIn: Pulse. https://www.linkedin.com/pulse/plan-apes-sound-science-must-inform-any-plans-gorillas-steve-osofsky.
Palacios, G., et al. (2011). Human metapneumovirus infection in wild mountain gorillas, Rwanda. Emerging Infectious Diseases, 17, 711–713.
PLOS ONE Editors. (2013). Expression of concern: Serological evidence of ebola virus infection in indonesian orangutans. PLoS One, 8, e60289.
Plumptre, A., et al. (2015). Status of grauer’s gorilla and chimpanzees in eastern democratic republic of Congo: Historical and current distribution and abundance. Unpublished report to Arcus Foundation, USAID and US fish and wildlife service
Purdy, J. (2016). The new nature. Boston Review, January 11.
Rabinowitz, P., Odofin, L., & Dein, J. (2008). From “us vs. them” to “shared risk”: can animals help link environmental factors to human health? EcoHealth, 5, 224–229.
Rifkin, S. (1996). Paradigms lost: Toward a new understanding of community participation in health programmes. Acta Tropica, 61, 79–92.
Ryan, S., & Walsh, P. (2011). Consequences of non-intervention for infectious disease in African great apes. PLoS One, 6, e290030.
Salmon, D., et al. (2013). Association between Guillain-Barre syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis. Lancet, 381, 1461–1468.
Scott, J., et al. (2016). Post-ebola syndrome, Sierra Leone. Emerging Infectious Diseases, 22, 641. doi:10.3201/eid2204.151302.
Smith, R., et al. (2003). Governance and loss of biodiversity. Nature, 426, 67–70.
Thielman, N. (2016). Ebola clinical trials: Five lessons learned and a way forward. Clinical Trials, 13, 83–86.
Wilcox, B., Gubler, D., & Pizer, H. (2007). Urbanization and the social ecology of emerging infectious diseases. In K. Mayer & H. Pizer (Eds.), Social ecology of infectious diseases (pp. 113–137). London: Academic Press.
Woodford, M., Butynski, T., & Karesh, W. (2002). Habituating the great apes: The disease risks. Oryx, 36, 153–160.